Obbligazione UnitedHealth Group 3.5% ( US91324PDJ84 ) in USD

UnitedHealth Group

99.977 USD ▲

Stati Uniti

US91324PDJ84 ( in USD )

3.5% per anno ( pagato 2 volte l'anno)

15/06/2023 - Obbligazione è scaduto

Prospetto opuscolo dell'obbligazione UnitedHealth Group US91324PDJ84 in USD 3.5%, scaduta

2 000 USD

750 000 000 USD

91324PDJ8

The Obbligazione issued by UnitedHealth Group ( United States ) , in USD, with the ISIN code US91324PDJ84, pays a coupon of 3.5% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 15/06/2023

Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-216150
June 14, 2018
UNITEDHEALTH GROUP INCORPORATED
FINAL TERM SHEET
Dated June 14, 2018
$350,000,000 FLOATING RATE NOTES DUE JUNE 15, 2021
Issuer:
UnitedHealth Group Incorporated
Ratings (Moody's / S&P / Fitch)*:
A3 (Stable) / A+ (Stable) / A- (Stable)
Note Type:
SEC Registered (No. 333-216150)
Trade Date:
June 14, 2018
Settlement Date (T+3):
June 19, 2018
Maturity Date:
June 15, 2021
Principal Amount Offered:
$350,000,000
Price to Public (Issue Price):
100.000%
Net Proceeds (Before Expenses) to Issuer:
$349,125,000 (99.750%)
Base Rate Spread:
LIBOR plus 26 basis points
Initial Interest Rate:
The interest rate in effect for the initial interest
period is based on an interpolated LIBOR
(between two-month and three-month LIBOR),
determined on the Initial Interest
Determination Date, plus 26 basis points
Interest Payment Dates and Interest Reset Dates:
March 15, June 15, September 15 and
December 15, commencing September 15,
2018
Interest Determination Dates:
Second London business day preceding the
applicable interest reset date
Initial Interest Determination Date:
June 15, 2018
Regular Record Dates:
15th calendar day (whether or not a business
day) preceding the applicable Interest Payment
Date

2

Optional Redemption Provisions:
None.
Change of Control:
If a Change of Control Triggering Event occurs,
the Company wil be required to make an offer
to repurchase the Notes at a price equal to
101% of the principal amount of the Notes,
plus accrued and unpaid interest to, but not
including, the date of repurchase.
Day count:
Actual/360
Business days:
Any day except a Saturday, a Sunday or a day
on which banking institutions in New York, New
York or Minneapolis, Minnesota are authorized
or required by law, regulation or executive
order to close, provided that, the day is also a
London business day.
London business day:
Any day on which dealings in United States
dol ars are transacted in the London interbank
market.
CUSIP / ISIN:
91324P DG4 / US91324PDG46
Joint Book-Running Managers:
Merril Lynch, Pierce, Fenner & Smith
Incorporated
Barclays Capital Inc.
Goldman Sachs & Co. LLC
Morgan Stanley & Co. LLC
RBC Capital Markets, LLC
Senior Co-Managers:
Citigroup Global Markets Inc.
Credit Suisse Securities (USA) LLC
HSBC Securities (USA) Inc.
J.P. Morgan Securities LLC
Mizuho Securities USA LLC
PNC Capital Markets LLC
U.S. Bancorp Investments, Inc.
Wel s Fargo Securities, LLC
Co-Managers:
BB&T Capital Markets, a division of BB&T
Securities, LLC
BMO Capital Markets Corp.
BNY Mel on Capital Markets, LLC
Deutsche Bank Securities Inc.
Drexel Hamilton, LLC
Fifth Third Securities, Inc.
KeyBanc Capital Markets Inc.
MUFG Securities Americas Inc.
Samuel A. Ramirez & Company, Inc.

3
Regions Securities LLC
Santander Investment Securities Inc.
SunTrust Robinson Humphrey, Inc.
TD Securities (USA) LLC
The Huntington Investment Company
The Wil iams Capital Group, L.P.
* Note: A securities rating is not a recommendation to buy, sel or hold securities and may be subject to revision,
suspension or withdrawal at any time.

4
FIXED RATE NOTES
$400,000,000 3.150% NOTES DUE JUNE 15, 2021
$750,000,000 3.500% NOTES DUE JUNE 15, 2023
$1,150,000,000 3.850% NOTES DUE JUNE 15, 2028
$1,350,000,000 4.250% NOTES DUE JUNE 15, 2048
Issuer:
UnitedHealth Group Incorporated
Ratings (Moody's / S&P / Fitch)*:
A3 (Stable) / A+ (Stable) / A- (Stable)
Note Type:
SEC Registered (No. 333-216150)
Trade Date:
June 14, 2018
Settlement Date (T+3):
June 19, 2018
Maturity Date:
June 15, 2021 (the "2021 Notes")
June 15, 2023 (the "2023 Notes")
June 15, 2028 (the "2028 Notes")
June 15, 2048 (the "2048 Notes")
Principal Amount Offered:
$400,000,000 (2021 Notes)
$750,000,000 (2023 Notes)
$1,150,000,000 (2028 Notes)
$1,350,000,000 (2048 Notes)
Price to Public (Issue Price):
99.946% (2021 Notes)
99.950% (2023 Notes)
99.828% (2028 Notes)
99.312% (2048 Notes)
Net Proceeds (Before Expenses) to Issuer:
$398,784,000 (99.696%) (2021 Notes)
$747,000,000 (99.600%) (2023 Notes)
$1,142,847,000 (99.378%) (2028 Notes)
$1,330,587,000 (98.562%) (2048 Notes)
Interest Rate:
3.150% (2021 Notes)
3.500% (2023 Notes)
3.850% (2028 Notes)
4.250% (2048 Notes)

5

Interest Payment Dates:
June 15 and December 15, commencing
December 15, 2018 (2021 Notes)
June 15 and December 15, commencing
December 15, 2018 (2023 Notes)
June 15 and December 15, commencing
December 15, 2018 (2028 Notes)
June 15 and December 15, commencing
December 15, 2018 (2048 Notes)
Regular Record Dates:
June 1 and December 1 (2021 Notes)
June 1 and December 1 (2023 Notes)
June 1 and December 1 (2028 Notes)
June 1 and December 1 (2048 Notes)
Benchmark:
T 2.625% due May 15, 2021 (2021 Notes)
T 2.750% due May 31, 2023 (2023 Notes)
T 2.875% due May 15, 2028 (2028 Notes)
T 3.000% due February 15, 2048 (2048 Notes)
Benchmark Price / Yield:
99-26 1/4 / 2.689% (2021 Notes)
99-23 / 2.811% (2023 Notes)
99-14 / 2.941% (2028 Notes)
98-26 / 3.061% (2048 Notes)
Spread to Benchmark:
+48 basis points (2021 Notes)
+70 basis points (2023 Notes)
+93 basis points (2028 Notes)
+123 basis points (2048 Notes)
Re-offer Yield:
3.169% (2021 Notes)
3.511% (2023 Notes)
3.871% (2028 Notes)
4.291% (2048 Notes)
Optional Redemption Provisions:
Make-whole cal at any time at a discount rate
of U.S. Treasury plus 10 basis points (2021
Notes).
Make-whole cal at any time at a discount rate
of U.S. Treasury plus 15 basis points (2023
Notes).
Make-whole cal at any time at a discount rate
of U.S. Treasury plus 15 basis points (2028
Notes).
Prior to December 15, 2047 (6 months prior to
their maturity date), make-whole cal at any
time at a discount rate of U.S. Treasury plus 20
basis points; par cal on or after December 15,
2047 (2048 Notes).

6

Change of Control:
If a Change of Control Triggering Event occurs,
the Company wil be required to make an offer
to repurchase the Notes at a price equal to
101% of the principal amount of the Notes,
plus accrued and unpaid interest to, but not
including, the date of repurchase.
Day Count:
30/360
Business Day
Any day except a Saturday, a Sunday or a day
on which banking institutions in New York, New
York or Minneapolis, Minnesota are authorized
or required by law, regulation or executive
order to close.
CUSIP / ISIN:
91324P DH2 / US91324PDH29 (2021 Notes)
91324P DJ8 / US91324PDJ84 (2023 Notes)
91324P DK5 / US91324PDK57 (2028 Notes)
91324P DL3 / US91324PDL31 (2048 Notes)
Joint Book-Running Managers:
Merril Lynch, Pierce, Fenner & Smith
Incorporated
Barclays Capital Inc.
Goldman Sachs & Co. LLC
Morgan Stanley & Co. LLC
RBC Capital Markets, LLC
Senior Co-Managers:
Citigroup Global Markets Inc.
Credit Suisse Securities (USA) LLC
HSBC Securities (USA) Inc.
J.P. Morgan Securities LLC
Mizuho Securities USA LLC
PNC Capital Markets LLC
U.S. Bancorp Investments, Inc.
Wel s Fargo Securities, LLC
Co-Managers:
BB&T Capital Markets, a division of BB&T
Securities, LLC
BMO Capital Markets Corp.
BNY Mel on Capital Markets, LLC
Deutsche Bank Securities Inc.
Drexel Hamilton, LLC
Fifth Third Securities, Inc.
KeyBanc Capital Markets Inc.
MUFG Securities Americas Inc.
Samuel A. Ramirez & Company, Inc.
Regions Securities LLC
Santander Investment Securities Inc.

7
SunTrust Robinson Humphrey, Inc.
TD Securities (USA) LLC
The Huntington Investment Company
The Wil iams Capital Group, L.P.
* Note: A securities rating is not a recommendation to buy, sel or hold securities and may be subject to revision,
suspension or withdrawal at any time.
UNDERWRITING
Page S-24 of the prospectus supplement is amended to add the fol owing section between the sections "--Offering
Restrictions--Singapore" and "--Other":
Taiwan
The notes have not been, and wil not be, registered with the Financial Supervisory Commission of Taiwan, the Republic
of China ("Taiwan") pursuant to applicable securities laws and regulations. No person or entity in Taiwan is authorized
to distribute or otherwise intermediate the offering of the notes or the provision of information relating to this
prospectus supplement and the accompanying prospectus. The notes may be made available for purchase outside
Taiwan by investors residing in Taiwan (either directly or through properly licensed Taiwan intermediaries acting on
behalf of such investors), but may not be issued, offered or sold in Taiwan. No subscription or other offer to purchase
the notes shal be binding on us until received and accepted by us or any underwriter outside of Taiwan (the "Place of
Acceptance"), and the purchase/sale contract arising therefrom shal be deemed a contract entered into in the Place of
Acceptance.
* * *
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange
Commission (the "SEC") for the offering to which this communication relates. Before you invest, you
should read the prospectus in that registration statement and other documents the issuer has filed with
the SEC for more complete information about the issuer and this offering. You may get these documents
for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter
or any dealer participating in the offering wil arrange to send you the prospectus if you request it by
cal ing Merril Lynch, Pierce, Fenner & Smith Incorporated tol -free at (800) 294-1322, Barclays Capital
Inc. tol -free at (888) 603-5847, Goldman Sachs & Co. LLC tol -free at (866) 471-2526, Morgan Stanley &
Co. LLC tol -free at (866) 718-1649 and RBC Capital Markets, LLC tol -free at 866-375-6829. Any
disclaimer or other notice that may appear below is not applicable to this communication and should be
disregarded. Such disclaimer or notice was automatical y generated as a result of this communication
being sent by Bloomberg or another email system.